Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment

doi:10.3748/wjg.v27.i25.3762

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4976)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

405

WORD

199

HTML

2691

Tables (1-4)

309

Sum=3604

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

629

Download

743

Sum=1372

Jul 7, 2021 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 7, 2021; 27(25): 3762-3779
Published online Jul 7, 2021. doi: 10.3748/wjg.v27.i25.3762

Table 2 Serologic profiles after initial screening

	HBsAg	Anti-HBc	Anti-HBs
Susceptible	Negative	Negative	Negative
Immune due to vaccination	Negative	Negative	Positive
HBV infection	Positive	Positive	Negative
Resolved HBV infection or occult HBV infection	Negative	Positive	Positive or negative

HBc: Hepatitis B core protein; HBs: Hepatitis B surface protein; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus.

Citation: Axiaris G, Zampeli E, Michopoulos S, Bamias G. Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment. World J Gastroenterol 2021; 27(25): 3762-3779
URL: https://www.wjgnet.com/1007-9327/full/v27/i25/3762.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i25.3762